Blog
Cisco's AI-Push Aids Networking Revenue: Is There More Upside Ahead?
Cisco Systems’ CSCO first-quarter fiscal 2026 networking revenues increased 15% on a year-over-year basis to $7.77 billion, driven by robust demand for AI infrastructure and campus networking
Broadcom's Semiconductor Growth Picks Up: A Sign of More Upside?
Broadcom’s AVGO Semiconductor revenues are benefiting from strong demand for XPUs, which are a type of application-specific integrated circuit (ASIC) necessary to train Generative AI (Gen AI)
BRK.B Stock Moves Above 50- & 200-Day SMA: Buy, Sell or Stay Invested?
Shares of Berkshire Hathaway Inc. BRK.B have gained momentum recently. The stock moved above its 50- as well as 200-day simple moving average (SMA) on Dec. 22, signaling a bullish trend.The 50-day
Top-Performing International ETFs of 2025
Wall Street experienced quite a volatility in 2025, while international markets remained relatively stable or gained momentum. Trade uncertainty under the Trump U.S. administration has fueled
Santa Rally for Metal ETFs as Gold, Silver & Platinum Hit Highs
Precious metals rallied to record highs ahead of Christmas. Gold edged past the $4,500-per-ounce mark for the first time on Wednesday, while silver and platinum also touched fresh all-time highs, as
Sandisk Stock Rides on Datacenter Growth: A Sign of More Upside?
Sandisk SNDK is riding on strong datacenter revenue growth, which increased 26% sequentially in the first quarter of fiscal 2026, driven by strong demand for the “Stargate” product line. Growing
4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow
The drug and biotech sector witnessed a see-saw performance in 2025. After a weak show for most of the year, the sector picked up in the past couple of months. This can be attributed to improved
Lumentum Stock Rides on Strong AI Push: A Sign of More Upside?
Lumentum LITE is riding on strong AI demand, which is driving the need for its laser chips and optical transceivers inside data centers, as well as in the interconnect and long-haul networks that
NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly?
Earlier this week, the FDA approved Eli Lilly and Company’s LLY rival Novo Nordisk’s NVO oral version of the obesity drug Wegovy (semaglutide). Wegovy is the first oral GLP-1 drug to be approved in
AI & Security Push Aids Google Cloud: What's Ahead for GOOGL Stock?
Alphabet GOOGL is riding on a strong Google Cloud prospect, which accounts for more than 14% of GOOGL’s revenues. In the trailing nine-month period ended Sept. 30, Google Cloud revenues jumped 31.2%
4 Auto Stocks Up More Than 50% YTD & Still Worth Buying for 2026
From tariff headlines to shifting EV incentives, the U.S. auto industry navigated sharp swings in sentiment and demand this year. Yet, despite the noise, consumer appetite for new vehicles has
Arkema Plans to Sell Plastic Additives Business to Praana
Arkema S.A. ARKAY has announced a proposed sale of part of its impact modifiers business and processing aids to the Indian group Praana to streamline and increase focus on its strategic activities
Implied Volatility Surging for Ultra Clean Stock Options
Investors in Ultra Clean Holdings, Inc. UCTT need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $15.00 Call had some of the
Xmas Eve Jobless Claims: Still Accommodating
Wednesday, December 24, 2025Pre-market futures are lower than yesterday’s close, which saw major indexes rise between +0.2% (Dow) and +0.6% (Nasdaq) on seasonal low volume (Xmas week), but hovering
Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know
Amgen AMGN recently signed a landmark agreement with the Trump administration to lower drug prices in the United States.
Through this deal, Amgen addresses the two major concerns that have plagued
Do Options Traders Know Something About Workiva Stock We Don't?
Investors in Workiva Inc. WK need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $40.00 Put had some of the highest implied
MRVL's Data Center Revenues Hit $1.5B: Can the Momentum Continue?
Marvell Technology MRVL posted strong results in the third quarter of fiscal 2026, which was led by its data center business. Revenues from the data center business reached $1.52 billion, up 38%
Best Momentum Stocks to Buy for Dec. 24
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 24th:
Zumiez Inc. ZUMZ: This retail apparel and footwear company has a Zacks Rank #1
ArcelorMittal Announces Renewable Energy Projects in India
ArcelorMittal S.A. MT announced three new renewable energy projects in India, expanding its portfolio. The projects are expected to increase MT’s renewable energy capacity in India by two-fold to 2
SMCI's Rack-Scale AI Strategy: Is it the Next Growth Engine?
Super Micro Computer SMCI in its first-quarter fiscal 2026 mentioned that it scaled up to an internal power capacity of 52 megawatts and is on track to scale up its rack capacity to 6,000 racks per
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health
For Immediate Release
Chicago, IL – December 24, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross?
X4 Pharmaceuticals, Inc. (XFOR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, XFOR's 50-day simple moving average crossed



.jpg?locale=de)
